Medicis Capital
6
18M
4
0.33
3
- Stages of investment
- Areas of investment
Summary
The company was established in Europe in Germany. The main department of described Corporate Investor is located in the Munich.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Medicis Capital, startups are often financed by Nexus Medical Partners, Innoven Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are Ventech, Saratoga Ventures, Nexus Medical Partners. In the next rounds fund is usually obtained by Valiance Asset Management, Accuitive Medical Ventures, Yorkville Advisors.
The top activity for fund was in 2010. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Medicis Capital is 100-500 millions dollars. This Medicis Capital works on 38 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Hybrigenics, EyeGate Pharmaceuticals, MyoScience Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 0
- Exits
- 3
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (6)
- Pharmaceutical (4)
- Therapeutics (3)
- Medical (2)
- Information Technology (1) Show 3 more
- Investments by region
-
- United States (4)
- France (1)
- United Kingdom (1)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 44M
- Group Appearance index
- 0.83
- Avg. company exit year
- 9
- Avg. multiplicator
- 4.41
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Hybrigenics | 01 Dec 2001 | Biotechnology, Therapeutics, Bioinformatics | Early Stage Venture | 15M | Ile-de-France, Paris, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.